Xenter Therapeutics

Xenter Therapeutics is a biotechnology company and a subsidiary of Xenter, Inc., focused on transforming interventional medicine through the integration of Physical Intelligence (PI). The company leverages a proprietary data platform that collects real-time physiological data during interventional procedures to guide the development of novel drug-device combinations and targeted therapeutics. Their primary focus areas include cardiovascular and vascular diseases, where they aim to improve patient outcomes by combining precision drug delivery with advanced sensing technologies. By utilizing large-scale clinical data, Xenter Therapeutics seeks to identify and validate new therapeutic targets for complex vascular conditions.